Merck Asks Justices To Block Fosamax Failure-To-Warn Suits
By Emily Field · March 13, 2025, 8:20 PM EDT
Merck has asked the U.S. Supreme Court to review a Third Circuit ruling that allowed more than 1,000 state-law failure-to-warn claims over its osteoporosis drug Fosamax, arguing that the U.S. Food...
To view the full article, register now.